BUPIVACAINE HYDROCH

Bupivacaine Hydrochloride Injection USP 0.5% in 50 mL vials is procured under solicitation SPE2DP-26-T-4017 with a single unit of issue and a total quantity of one package, to be delivered within 20 days to Fort Hood, Texas. The product must be stored at controlled room temperature between 20 to 25°C and has a non-extendable shelf life of 24 months, adhering to strict shelf-life requirements for Type I (Code M) items. It is regulated by the FDA and requires pre-award confirmation via EBS referral, including manufacturer and bidder details. Packaging must comply with MIL-STD-129 and the DLA Master List of Technical and Quality Requirements, replacing ASTM D3951 when applicable, and hazardous material handling protocols must be followed per Fed-Std-313 and TQ IP025 if applicable. The item is to be shipped by traceable means only, excluding parcel post, and must be marked according to the latest Medical Marking Standard No. 1. Manufacturer is Pfizer Inc with NDC 00409-1163-18, and the NSN is 6505-00-138-7347. All packaging and labeling must reflect DLA packaging requirements and unit of issue specifications. Delivery is FOB destination with zero variance allowed on quantity. Required delivery date is July 8, 2026, with the solicitation issued on July 6, 2026, and response deadline on July 13, 2026. The contracting office is part of the Department of Defense’s Medical Supply Chain, managed by James Foggie.